Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.
Clinical trial NCT02294396 · COMPLETED
Trial details
- NCT number
- NCT02294396
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2016-09-07
- Enrollment
- 649
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.